View Older Stories View More Recent Stories

Oct 9, 2023 08:00AM MBX Biosciences Doses First Participant in Phase 1/2 Clinical Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
Oct 5, 2023 05:09PM Form SC 13G SOLENO THERAPEUTICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 5, 2023 08:00AM Jnana Therapeutics to Participate in Upcoming Investor Conferences
Oct 5, 2023 07:30AM SAB Biotherapeutics Approves Appointment of Andrew Moin to Board of Directors
Oct 5, 2023 04:44AM Orchard Therapeutics (ORTX) Acquired by Kyowa Kirin for $16/sh Cash plus $1 CVR
Oct 3, 2023 08:00AM MBX Biosciences to Showcase Results from Phase 1 Study of MBX 2109 in Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research Annual Meeting
Oct 2, 2023 07:31AM SAB Biotherapeutics (SABS) Announces Private Placement of up to $130 Million
Oct 2, 2023 07:30AM SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes
Sep 29, 2023 05:01PM Form SC 13G CHIMERIX INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Sep 27, 2023 09:00AM T-knife Therapeutics Announces Four Presentations at the Upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting
Sep 25, 2023 04:31PM Form SC 13D/A ARS Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Sep 25, 2023 09:00AM Adela Announces $48 Million in Financing and Leadership Addition to Advance Tissue-Agnostic Minimal Residual Disease (MRD) Monitoring Product Portfolio Based on Genome-Wide Methylome Approach
Sep 22, 2023 04:30PM Form SC 13G CymaBay Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Sep 19, 2023 05:25PM Form SC 13D/A Cytek Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Sep 19, 2023 10:04AM Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery
Sep 13, 2023 06:30AM EntityRisk Launches PROVEN™ Platform
Sep 11, 2023 08:00AM MBX Biosciences Announces Positive Phase 1 Multiple Ascending Dose Data for MBX 2109, a Long-Acting Parathyroid Hormone Peptide Prodrug, in Healthy Adults
Sep 7, 2023 06:30AM Mariana Oncology Announces $175 Million Series B Financing
Sep 6, 2023 08:00AM Jnana Therapeutics to Participate in Upcoming Investor Conferences
Sep 6, 2023 07:00AM Nimbus Therapeutics Secures $210M Private Financing to Advance Next Wave of Tech-Enabled Small Molecule Medicines
Sep 5, 2023 07:00AM Star Therapeutics Raises $90 Million Financing to Accelerate Its Pipeline of Novel Antibody Therapies and Growth of Its Portfolio Companies
Sep 5, 2023 07:00AM Sortera Technologies Attends IAA Mobility 2023 Conference in Munich
Aug 31, 2023 05:26PM Form SC 13D ARS Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 31, 2023 07:00AM Jnana Therapeutics Presents Additional Data from Phase 1a Clinical Study of JNT-517 at SSIEM Annual Symposium
Aug 30, 2023 11:30AM Sortera Technologies Closes $30.5 Million in New Funding to Fully Commercialize Its State-of-the-Art Upcycling Facility
Aug 29, 2023 09:01AM Inhibrx Inc. (INBX) Announces $200M Financing at $19.35/sh
Aug 29, 2023 09:00AM Inhibrx Announces $200 Million Private Placement Financing
Aug 29, 2023 08:00AM MBX Biosciences to Participate in Morgan Stanley Global Healthcare Conference
Aug 28, 2023 07:30AM Superluminal Medicines Launches with $33 Million Seed Round to Fuel its Drug Discovery Engine and Pipeline of Small Molecule Therapeutics
Aug 25, 2023 05:02PM Form SC 13G Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 24, 2023 11:37AM ExcepGen Emerges From Stealth with New Funding for its Nucleic Acid Therapeutics Platform
Aug 21, 2023 04:31PM Form SC 13G Gracell Biotechnologies Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 17, 2023 04:30PM Form SC 13G NEKTAR THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 17, 2023 06:30AM Abcuro Announces $155 Million Oversubscribed Series B Financing to Further Advance Autoimmune Pipeline
Aug 15, 2023 10:42PM AN2 Therapeutics Announces Pricing of $70.0 Million Underwritten Offering of Common Stock
Aug 14, 2023 05:02PM Form SC 13G/A BELLUS Health Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2023 05:00PM Form SC 13G/A Kinnate Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2023 04:31PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30
Aug 14, 2023 07:15AM Gracell Biotechnologies Reports Second Quarter 2023 Unaudited Financial Results and Provides Corporate Update
Aug 14, 2023 07:02AM Taysha Gene Therapies (TSHA) Reports Initial Clinical Data from First Adult Rett Syndrome Patient Dosed in REVEAL Phase 1/2 Trial
Aug 14, 2023 07:02AM Taysha Gene Therapies Reports Initial Clinical Data from First Adult Rett Syndrome Patient Dosed in REVEAL Phase 1/2 Trial and Provides Corporate Update with Second Quarter 2023 Financial Results
Aug 14, 2023 07:00AM Taysha Gene Therapies (TSHA) Announces $150M Financing
Aug 14, 2023 07:00AM Taysha Gene Therapies Announces $150 Million Private Placement Financing
Aug 11, 2023 05:06PM Form SC 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 11, 2023 05:02PM Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 9, 2023 05:00PM Form SC 13D/A DICE Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 9, 2023 07:00AM Jnana Therapeutics Announces Dosing of First Participant in Phase 1b Clinical Trial of JNT-517 in Individuals with PKU
Aug 7, 2023 08:00AM MBX Biosciences Announces U.S. FDA Clearance of IND Application for MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
Aug 7, 2023 07:48AM Gracell Biotechnologies (GRCL) Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
Aug 7, 2023 07:45AM Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
View More Recent Stories View Older Stories